Kriti Nutrients Limited has informed the Exchange regarding ''.Regulation 33 of SEBI (LODR) Regulations, 2015- Submission of Unaudited Standalone and Consolidated Financial Results along with Limited Review Report for the Quarter ended 30th June, 2025
KRITINUT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kriti Nutrients reported Q1 FY26 revenue from operations of ₹22,904 lakhs, up about 22% from ₹18,782 lakhs in Q1 FY25. Despite the strong top-line growth, standalone net profit fell sharply to ₹921 lakhs from ₹1,427 lakhs in the year-ago quarter, a decline of roughly 35%. Total expenses rose to ₹21,922 lakhs (vs ₹17,069 lakhs), driven mainly by higher raw material costs, which squeezed the operating margin to about 5.2% from 10% a year ago. Consolidated net profit (including associate Kriti Industries India) was ₹949 lakhs. On a sequential basis, net profit recovered strongly from ₹495 lakhs in Q4 FY25. The statutory auditor issued an unmodified (clean) limited review report and there were no exceptional items.
The headline shows healthy revenue growth, but the steep drop in net profit and halving of the operating margin may worry shareholders looking at profitability rather than just topline. Investors should watch whether the margin pressure is driven by temporary input cost spikes or a structural issue, as this could influence near-term stock sentiment.